Centre de Recherche en Maladies Tropicales de l'Ituri Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2019
NCT03876262
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Centre de Recherche en Maladies Tropicales de l'Ituri

Active Ingredients

Drugs in Phase 3 Trials (2)

ivermectin (stromectol) (2 trials)

moxidectin (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Onchocerciasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2